 Home > Biochemistry News > Biotechnology News > Bristol-Myers Squibb's CAR-T therapy for second-line treatment of large B-cell lymphoma gets priority review

Bristol-Myers Squibb's CAR-T therapy for second-line treatment of large B-cell lymphoma gets priority review

 Last Update: 2022-05-01
 Source: Internet
 Author: User

Tags

sucrose side effects

hydrogen cell car

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On February 17, 2022, Bristol-Myers Squibb (BMS) announced that the U.

Breyanzi is an autologous CAR-T cell therapy targeting the CD19 antigen with a well-defined composition and 4-1BB co-stimulatory domain

This application is based on positive results from a pivotal Phase 3 clinical trial

Trial results showed that patients in the Breyanzi group achieved highly statistically and clinically meaningful improvements in event-free survival (EFS), complete response rate (CRR), and progression-free survival (PFS) compared to the standard-of-care group , and overall survival (OS) showed a positive trend

References:

[1] US Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb's Supplemental Biologics License Application for Breyanzi (lisocabtagene maraleucel) as a Second-Line Therapy for Relapsed or Refractory Large B-cell Lymphoma.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.